Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
Date:8/8/2013

set by lower apatorsen manufacturing costs due to the timing of manufacturing activities.
  • Net loss for the second quarter and six months ended June 30, 2013 was $8.4 million, or $0.57 per diluted common share, and $15.1 million, or $1.03 per diluted common share, respectively. Net loss for the second quarter and six months ended June 30, 2012 was $4.2 million, or $0.29 per diluted common share, and $11.1 million, or $0.89 per diluted common share, respectively. The net loss in the six months ended June 30, 2013 included a non-cash gain on revaluation of the warrant liability of $2.3 million. 
  • The Company had $57.0 million in cash, cash equivalents and short-term investments as of June 30, 2013, compared to $75.4 million as of December 31, 2012.
  • 2013 cash guidance:
  • Net cash requirements are expected to be in the range of $40 - $50 million.
  • Year-end cash, cash equivalents and short-term investments are expected to be in the range of $25 - $35 million.
  • Based on its current expectations, the Company believes its capital resources as of June 30, 2013 will be sufficient to fund its currently planned operations into 2015.
  • At August 8, 2013, The Company had 14,680,395 shares outstanding.
  •  Consolidated Statements of Loss(In thousands, except per share and share data)(unaudited)Three months ended June 30,Six months ended June 30,2013201220132012Collaboration revenue

    $
    ,340$
    2,429$
    ,416$
    3,745Operating expenses:  Research and development

    13,2636,32624,11811,408  General and administrative

    2,4732,0474,9733,784Total operating expenses

    15,7368,37329,09115,192Loss from operations

    (9,396)(5,944)(17,675)(11,447)  Other income (expense)

    9761,7292,558372Net loss

    $
    (8,420)$
    (4,215)$
    (15,117)$
    (11,075)Basic and diluted net loss per share

    $
    (0.57)$
    (0.29)$
    (1.03)$<
    '/>"/>

    SOURCE OncoGenex Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. OncoGenex Announces Multiple Trials in Progress Presentations at the 2013 ASCO Annual Meeting
    2. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
    3. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
    4. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
    5. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
    6. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
    7. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
    8. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
    9. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
    10. OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.
    11. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... Sept. 1, 2015 Taiwan,s ... press conference in Taipei on  ... new Vaucarrin™ platform, a targeted drug delivery technology that ... This event was part of a joint press conference ... NanoTech Inc. (GNT), showcasing GNT,s latest edible gold-based food ...
    (Date:9/1/2015)... California , September 1, 2015 ... is segmented on the basis of sectors, products ... chronic diseases globally coupled with the increasing demand ... diseases are expected to propel the growth for ... manage biological information efficiently is known as bioinformatics. ...
    (Date:9/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rd9jbr/introduction_to ) ... to Veterinary Pharmacovigilance (London, UK - September 23-24)" ... This course has been designed to provide basis ... with Veterinary Pharmacovigilance. New entrants, support staff we ... understanding of veterinay drug safety will benefit from ...
    Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
    ... 27, 2011 Surgical facilities are facing unprecedented challenges ... volume, combined with shrinking budgets and lowered staffing levels, ... the best value when purchasing surgical instruments . ... equally as important as price. Most US-based ...
    ... 27, 2011 The Smithsonian,s National Museum ... of CT scanning technology in non-invasive scientific ... Siemens SOMATOM Emotion 6 CT scanner from ... about museum objects that is fundamentally changing ...
    Cached Medicine Technology:American-Made Surgical Instruments Meet the High Demands of Surgical Facilities 2Smithsonian Uses Siemens CT Scanner to Unlock Secrets of the Past 2Smithsonian Uses Siemens CT Scanner to Unlock Secrets of the Past 3Smithsonian Uses Siemens CT Scanner to Unlock Secrets of the Past 4
    (Date:9/1/2015)... ... September 01, 2015 , ... METTLER TOLEDO has announced an ... GMP requirements“ , featuring Ed Szczesny (Quality Assurance, Rhodes Pharmaceuticals) as guest presenter. ... GMT). , Calibration, qualification, and the appropriate level of routine testing for ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... Nurse Scholar-in Residence at the Institute of Medicine (IOM) of the National Academies. ... at Columbia University School of Nursing. A member of the Institute of Medicine ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... 1,500 investor-families have received permanent green cards (I-829 petition approval) from the USCIS ... petition is the final step of the EB-5 visa process for immigrant investors ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... from 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland ... opportunities will be attending from across the country. All specialties will be represented. ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Situations requiring fast, easy-to-understand ... the most convenient time for everyone involved. These occasions highlight the value of ... Translation Services has real people available to handle any translation assignment at ...
    Breaking Medicine News(10 mins):Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3
    ... Avina knows all too well the devastating injuries all-terrain vehicles ... sister, Rociel, hopped on an ATV for a little innocent ... riding tandem with his sister when a bird flew into ... sending Cristian and Rociel flyingneither was wearing a helmet. ...
    ... Major employers join with Blue Cross and Blue ... healthier behavior, WASHINGTON, July 14 Recognizing ... spending, many employers are,taking a "hands on" approach ... that address smoking, obesity, and disease prevention,and management. ...
    ... Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) ... stated that Zimmer,s,NexGen(R) knee implant had been recalled. In ... instrument used for minimally invasive,surgeries (MIS) and not the ... isolated to a single surgical instrument and that additional,instrumentation ...
    ... health, at least among men, a new study shows. ... M.D., D.Sc., found that men who believed they were ... three times lower incidence of death from heart attacks ... same conclusion among women. One possible explanation for the ...
    ... Division of Theoretical Bioinformatics at the German Cancer Research ... the computer how cells decide whether or not to ... predict the molecular targets within a cell that have ... a particular direction. This method may help to develop ...
    ... announced the appointment of Gregory Ciottone,MD to the position of Chief ... ... Company., LONGMONT, Colo., July 14 ... Ciottone, MD,to the position of Chief Medical Officer. Dr. Ciottone will ...
    Cached Medicine News:Health News:Gear up before revving up ATVs 2Health News:Employers Take Active Role in Promoting Workplace Wellness 2Health News:Employers Take Active Role in Promoting Workplace Wellness 3Health News:Zimmer Holdings Issues Clarification Regarding NexGen Knee System 2Health News:Zimmer Holdings Issues Clarification Regarding NexGen Knee System 3Health News:Positive thinking is prescription for the heart 2Health News:Cellular decision on the computer 2Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 2Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 3Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 4Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 5
    Hudson hand drill with extension piece....
    Disposable 14 mm drill is designed to make 14 mm diameter orifices. It features a self-locking facility....
    The Greenberg retractor and handrest is a versatile, three level system offering efficient space planning, whereby each level has an assigned surgical task....
    Io is a surgical digital microscope with head mounted display HMD (Callisto)....
    Medicine Products: